Role of Heme Oxygenase in Modulating Endothelial Function in Mesenteric Small Resistance Arteries of Spontaneously Hypertensive Rats

References

• Brunner H, Cockcroft JR, Deanfield J, Donald A, Ferrannini E, Halcox J, Kiowski W, Luscher TF, Mancia G, Natali A, Oliver JJ, Pessina AC, Rizzoni D, Rossi GP, Salvetti A, Spieker LE, Taddei S, Webb DJ, the Working Group on Endothelins and Endothelial Factors of the European Society of Hypertension. Endothelial function and dysfunction. Part II: Association with cardiovascular risk factors and diseases. A statement by the Working Group on Endothelins and Endothelial Factors of the European Society of Hypertension. J Hypertens 2005;23:233–246.
   PubMed Web of Science ®Google Scholar
• Drexler H. Endothelial dysfunction: Clinical implications. Prog Cardiovasc Dis 1997; 39:287–324.
   PubMed Web of Science ®Google Scholar
• Taddei S, Salvetti A. Endothelial dysfunction in essential hypertension: Clinical implications. J Hypertens 2002; 20:1671–1674.
   PubMed Web of Science ®Google Scholar
• Morita T. Heme oxygenase and atherosclerosis. Arterioscler Thromb Vasc Biol 2005; 25:1786–1795.
   PubMed Web of Science ®Google Scholar
• Mulvany MJ, Aalkjaer C. Structure and function of small arteries. Physiol Rev 1990; 70:921–961.
   PubMed Web of Science ®Google Scholar
• Deng LY, Li JS, Schiffrin EL. Endothelium-dependent relaxation of small arteries from essential hypertensive patients: Mechanisms and comparison with normotensive subjects and with responses of vessels from spontaneous hypertensive rats. Clin Sci 1995; 88:611–622.
   PubMed Web of Science ®Google Scholar
• Rizzoni D, Porteri E, Castellano M, Bettoni G, Muiesan ML, Tiberio G, Giulini SM, Rossi GP, Bernini G, Agabiti Rosei E. Endothelial dysfunction in hypertension is independent from the etiology and from vascular structure. Hypertension 1998; 31(part 2):335–341.
   PubMedGoogle Scholar
• Wu L, Wang R. CO monoxide: Endogenous production, physiological functions, and pharmacological applications. Pharmacol. Rev 2005; 57:585–630.
   PubMed Web of Science ®Google Scholar
• Mulvany MJ, Aalkjaer C. Structure and function of small arteries. Physiol Rev 1990; 70:921–971.
   PubMed Web of Science ®Google Scholar
• Rizzoni D, Castellano M, Porteri E, Bettoni G, Muiesan ML, Agabiti-Rosei E. Vascular structural and functional alterations before and after the development of hypertension in SHR. Am J Hypertens 1994; 7:193–200.
   PubMed Web of Science ®Google Scholar
• Mulvany MJ, Hansen PK, Aalkjaer C. Direct evidence that the greater contractility of resistance vessels in spontaneously hypertensive rats is associated with a narrowed lumen, a thickened media, and an increased number of smooth muscle cell layers. Circ Res 1978; 43:854–864.
   PubMed Web of Science ®Google Scholar
• Rizzoni D, Castellano M, Porteri E, Bettoni G, Muiesan ML, Agabiti Rosei E. Delayed development of hypertension after short-term nitrendipine treatment. Hypertension 1994; 24:131–139.
   PubMed Web of Science ®Google Scholar
• Vecchione C, Frata L, Rizzoni D, Notte A, Poulet R, Porteri E, Frati G, Guelfi D, Trimarco V, Mulvany MJ, Agabiti Rosei E, Trimarco B, Cotecchia S, Lembo G. Cardiovascular influences of α1B-adrenergic receptor in mice. Circulation 2002; 105:1700–1707.
   PubMed Web of Science ®Google Scholar
• Brunner H, Cockcroft JR, Deanfield J, Donald A, Ferrannini E, Halcox J, Kiowski W, Lüscher TF, Mancia G, Natali A, Oliver JJ, Pessina AC, Rizzoni D, Rossi GP, Salvetti A, Spieker LE, Taddei S, Webb DJ, the Working Group on Endothelins and Endothelial Factors of the European Society of Hypertension. Endothelial function and dysfunction. Part II: Association with cardiovascular risk factors and diseases. A statement by the Working Group on Endothelins and Endothelial Factors of the European Society of Hypertension. J Hypertens 2005, 23:233–246.
   PubMed Web of Science ®Google Scholar
• Rizzoni D, Porteri E, Guelfi D, Muiesan ML, Valentini U, Cimino A, Girelli A, Rodella L, Bianchi R, Sleiman I, Agabiti Rosei E. Structural alterations in subcutaneous small arteries of normotensive and hypertensive patients with non-insulin-dependent diabetes mellitus. Circulation 2001; 103:1238–1244.
   PubMed Web of Science ®Google Scholar
• Yet SF, Layne MD, Liu X, Chen YH, Ith B, Sibinga NE, Perrella MA. Absence of heme oxygenase-1 exacerbates atherosclerotic lesion formation and vascular remodeling. FASEB J 2003;17: 1759–1761.
   PubMed Web of Science ®Google Scholar
• Durante W. Heme oxygenase-1 in growth control and its clinical application to vascular disease. J Cell Physiol 2003;195:373–382.
   PubMed Web of Science ®Google Scholar
• Duckers HJ, Boehm M, True AL, Yet SF, San H, Park JL, Clinton Webb R, Lee ME, Nabel GJ, Nabel EG. Heme oxygenase-1 protects against vascular constriction and proliferation. Nat Med 2001; 7:693–698.
   PubMed Web of Science ®Google Scholar
• Liu XM, Chapman GB, Wang H, Durante W. Adenovirus-mediated heme oxygenase-1 gene expression stimulates apoptosis in vascular smooth muscle cells. Circulation 2002; 105:79–84.
   PubMed Web of Science ®Google Scholar
• Öllinger R, Bilban M, Erat A, Froio A, McDaid J, Tyagi S, Csizmadia E, Graça-Souza AV, Liloia A. Soares MP, Otterbein LE, Usheva A, Yamashita K, Bach FH. Bilirubin A: Natural inhibitor of vascular smooth muscle cell proliferation. Circulation 2005;112:1030–1039.
   PubMed Web of Science ®Google Scholar
• Barceloux DG. Cobalt. J Toxicol Clin Toxicol 1999;37:201–206.
   PubMed Web of Science ®Google Scholar
• Pislaru S, Janssens SP, Gersh BJ, Simari RD. Defining gene transfer before expecting gene therapy: Putting the horse before the cart. Circulation 2002; 106:631–636.
   PubMed Web of Science ®Google Scholar
• Otterbein LE, Zuckerbraun BS, Haga M, Liu F, Song R, Usheva A, Stachulak C, Bodyak N, Smith RN, Csizmadia E, Tyagi S, Akamatsu Y, Flavell RJ, Billiar TR, Tzeng E, Bach FH, Choi AM, Soares MP. CO monoxide suppresses arteriosclerotic lesions associated with chronic graft rejection and with balloon injury. Nat Med 2003; 9:183–190.
   PubMed Web of Science ®Google Scholar
• Abraham NG, Kappas A. Pharmacological and clinical aspects of heme oxygenase. Pharmacol Rev 2008; 60:79–127.
   PubMed Web of Science ®Google Scholar
• Stocker R, Yamamoto Y, McDonagh AF, Glazer AN, Ames BN. Bilirubin is an antioxidant of possible physiological importance. Science 1987; 235:1043–1046.
   PubMed Web of Science ®Google Scholar
• Kawamura K, Ishikawa K, Wada Y, Kimura S, Matsumoto H, Kohro T, Itabe H, Kodama T, Maruyama Y. Bilirubin from heme oxygenase-1 attenuates vascular endothelial activation and dysfunction. Arterioscler Thromb Vasc Biol 2005; 25:155–160.
   PubMed Web of Science ®Google Scholar
• Novotny L, Vitek L. Inverse relationship between serum bilirubin and atherosclerosis in men: a meta-analysis of published studies. Exp Biol Med 2003; 228:568–571.
   PubMed Web of Science ®Google Scholar
• L’Abbate A, Neglia D, Vecoli C, Novelli M, Ottaviano V, Baldi S, Barsacchi R, Paolicchi A, Masiello P, Drummond GS, McClung JA, Abraham NG. Beneficial effect of heme oxygenase-1 expression on myocardial ischemia-reperfusion involves an increase in adiponectin in mildly diabetic rats. Am J Physiol Heart Circ Physiol 2007; 293:H3532–H3541.
   PubMed Web of Science ®Google Scholar
• Ollinger R, Wang H, Yamashita K, Wegiel B, Thomas M, Margreiter R, Bach FH. Therapeutic applications of bilirubin and biliverdin in transplantation. Antioxid Redox Signal 2007; 9:2175–2185.
   PubMed Web of Science ®Google Scholar
• Wang R, Shamloul R, Wang X, Meng Q, Wu L. Sustained normalization of high blood pressure in spontaneously hypertensive rats by implanted hemin pump. Hypertension 2006; 48:685–692.
   PubMed Web of Science ®Google Scholar
• Ndisang JF, Zhao W, Wang R. Selective regulation of blood pressure by heme oxygenase-1 in hypertension. Hypertension 2002; 40;315–321.
   PubMed Web of Science ®Google Scholar
• Wang R, Ndisang JF, Wang X, Shamloul R, Wu L. Unprecedented long-lasting normalization of hypertension by a hemin therapy. Circulation 2005;112:II–511 (Abstract).
   Google Scholar
• Stasch JP, Schmidt PM, Nedvetsky PI, Nedvetskaya TY, Kumar AHS, Meurer S, Deile M, Taye A, Knorr A, Lapp A Müller H, Turgay Y, Rothkegel C, Tersteegen A, Kemp-Harper B. Müller-Esterl W, Schmidt HHHW. Targeting the heme-oxidized nitric oxide receptor for selective vasodilatation of diseased blood vessels. J Clin Invest 2006; 116:2552–2561.
   PubMed Web of Science ®Google Scholar
• Kumar S, Bandyopadhyay U. Free heme toxicity and its detoxification systems in human. Toxicology Letters 2005; 157:175–188.
   PubMed Web of Science ®Google Scholar
• Galbraith RA, Kappas A. Regulation of food intake and body weight in rats by the synthetic heme analogue cobalt protoporphyrin. Am J Physiol 1991; 261(6 Pt 2):R1388–1394.
   PubMed Web of Science ®Google Scholar
• von Dobschuetz E, Schmidt R, Scholtes M, Thomusch O, Schwer CI, Geiger KK, Hopt UT, Pannen BH. Protective role of heme oxygenase-1 in pancreatic microcirculatory dysfunction after ischemia/reperfusion in rats. Pancreas 2008; 36:377–384.
   PubMed Web of Science ®Google Scholar
• Turnbull AV, Kim CK, Lee S, Rivier CL. Influence of carbon monoxide, and its interaction with nitric oxide, on the adrenocorticotropin hormone response of the normal rat to a physico-emotional stress. J Neuroendocrinol 1998; 10:793–802.
   PubMed Web of Science ®Google Scholar